Hydroxyurea toxicity in human immunodeficiency virus-positive patients

被引：7

作者：

Goodrich, J ^{[1
]}

Khardori, N ^{[1
]}

机构：

[1] So Illinois Univ, Sch Med, Springfield, IL 62794 USA

来源：

CLINICAL INFECTIOUS DISEASES | 1999年 / 29卷 / 03期

关键词：

D O I：

10.1086/598663

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：692 / 693

页数：2

共 5 条

[1] Target cell availability and the successful suppression of HIV by hydroxyurea and didanosine [J].

De Boer, RJ ;

Boucher, CAB ;

Perelson, AS .

AIDS, 1998, 12 (13) :1567-1570

[2]

DONEHOWER RC, 1992, SEMIN ONCOL, V19, P11

[3]

Foli A, 1998, AIDS, V12, P1113

[4] A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection [J].

Rutschmann, OT ;

Opravil, M ;

Iten, A ;

Malinverni, R ;

Vernazza, PL ;

Bucher, HC ;

Bernasconi, E ;

Sudre, P ;

Leduc, D ;

Yerly, S ;

Perrin, LH ;

Hirschel, B .

AIDS, 1998, 12 (08) :F71-F77

[5] Hydroxyurea treatment in HIV-infested patients [J].

Simonelli, C ;

Nasti, G ;

Vaccher, E ;

Tirelli, U ;

Zanussi, S ;

DePaoli, P ;

Comar, M ;

Giacca, M .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (05) :462-464

← 1 →